NASDAQ · PRWCX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:07 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
T. Rowe Price Capital Appreciation Fund’s quoted price sits in the upper half of its reported 52-week range, 0.38% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
T. Rowe Price Capital Appreciation Fund’s forward annual dividend is $3.15 per share, paid annual. The forward yield is 8.04% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This fund's primary goal is to achieve substantial capital growth over the long term. It typically commits at least half of its total assets to equities. The remaining portion of its portfolio is generally diversified across convertible securities, various forms of corporate and government debt (including those backed by mortgages and other assets), and bank loans, which represent a share in credit extended by a group of lenders to a borrower. The fund also has the flexibility to invest up to 25% of its assets in international securities.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:15 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$22.21+$0.06 (+0.27%)
American Funds 2050 Target Date Retirement Fund Class A’s quoted price sits in the upper half of its reported 52-week range, 2.37% below the high.
$68.11-$0.11 (-0.16%)
Vanguard Target Retirement 2060 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.41% below the high.
$30.03-$0.14 (-0.46%)
MFS International Diversification Fund Class A’s quoted price sits in the upper half of its reported 52-week range, 4.55% below the high.
$200.40-$0.61 (-0.3%)
T. Rowe Price Equity Index 500 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.23% below the high.
$221.60+$3.77 (+1.73%)
Vanguard Health Care Fund Investor Shares’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$200.55-$2.86 (-1.41%)
MFS Growth Fund’s quoted price sits in the upper half of its reported 52-week range, 12.81% below the high.
$102.78+$0.25 (+0.24%)
T. Rowe Price Mid-Cap Growth Fund’s quoted price sits in the upper half of its reported 52-week range, 2.15% below the high.
$14.15+$0.01 (+0.07%)
Vanguard Target Retirement Income Fund’s quoted price sits in the upper half of its reported 52-week range, 2.01% below the high.
